# PharmatrophiX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pharmatrophix

- Industry: Biotechnology
- Headquarters: Raleigh, US
- Website: www.pharmatrophix.com
- Total disclosed funding: $5.5M
- Latest round: Series A (Oct 6, 2014)
- Investors on record: 1

## About

Based in North Carolina, US, and founded in 2005 by founder Frank Longo, PharmatrophiX is engaged in developing drugs for neurodegenerative diseases and other disorders. In October 2014, Dolby Family Ventures completed a USD 5.5 million Series A round of financing for PharmatrophiX.

PharmatrophiX offers disease-modifying small-molecule drugs to slow or prevent the progression of neurodegenerative diseases by targeting the underlying biological mechanisms. The company utilizes a virtual business model and focuses on drugs that promote synaptic resilience in the brain.

## Funding rounds

- Series A, Oct 6, 2014, $5.5M — Dolby Family Ventures

## Investors

- Dolby Family Ventures (https://capitalatlas.ai/funds/dolby-family-ventures) — Series A